Moreover, CDH1 and FOXA2 are linked to each other in carcinoma progression, evidenced by the loss of silencing FOXA2 leading to E-cadherin downregulation, EMT and metastasis [71,72]. This evidence concerns the gene FOXA2 and carcinoma.